Background: CD14 promoter DNA sequence polymorphisms for the endotoxin receptor gene have been implicated in modulating allergen-specific immunoglobulin (Ig)E responses in randomly selected individuals with atopy. We sought to determine if a single nucleotide polymorphism in the CD14 promoter region is associated with atopy in atopic families, and to assess its influence on serum levels of CD14 and allergen-specific IgE and IgG1 responses. Methods: We screened 367 members of 91 Caucasian nuclear families with a history of asthma for pulmonary function by spirometry, including methacholine challenge to detect bronchial hyperreactivity, and atopy by serum total IgE and skin prick test to 14 allergens. The CD14 promoter single nucleotide polymorphism was analyzed in DNA isolated from peripheral blood mononuclear cells to identify C/C, C/T and T/T genotypes. Serum tests were done for soluble CD14 (sCD14) and dust mite-specific antibody (Der p 1-IgG1). Results: Serum sCD14 levels were not associated with clinical phenotypes (asthma, bronchial hyperreactivity or atopy). However, sCD14 levels were inversely related to both allergen-specific IgE and Der p 1-IgG1 production, but only among those with evidence of atopic sensitization. Linear regression analysis, accounting for random family effects, demonstrated a higher production of allergen-specific IgE or Der p 1-IgG1 associated with the T/T genotype and a lower level of specific IgE and IgG1 production associated with sCD14 levels. Conclusions: An element of the innate immune system (CD14) has profound effects upon modulating the acquired allergen-specific immunoglobulin responses among those with an inherited atopic predisposition.

Keywords:
Atopy, CD14, Immunoglobulin E, Immunoglobulin G1, Der p 1, Single nucleotide polymorphism
1.
Blumenthal MN, Björkstén B (eds): Genetics of Allergy and Asthma. New York, Marcel Dekker, 1997.
2.
Blumenthal MN: What we know about the genetics of asthma at the beginning of the 21st century; in Hopp R (ed): Clinical Review in Allergy and Asthma. New Jersey, Human Press, 2002, pp 11–32.
3.
Hoffjan S, Ober C: Present status on the genetics of asthma. Curr Opin Immunol 2002;14:709–717.
4.
Wills-Karp M, Ewart SL: Time to draw breath: asthma-susceptibility genes are identified. Nat Rev Genet 2004;5:376–387.
5.
Batard T, Basuyaux B, Lambin P, Bremard-Oury C, Hamilton RG, David B, Peltre G: Isotypic analysis of grass pollen-specific immunoglobulins in human plasma. 1. Specialization of certain classes and subclasses in the immune response. Int Arch Allergy Immunol 1993;100:68–78.
6.
Batard T, Basuyaux B, Laroze A, Lambin P, Bremard-Oury C, Aucouturier P, Hamilton RG, David B, Peltre G: Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies. Int Arch Allergy Immunol 1993;102:279–287.
7.
Jackola DR, Pierson-Mullany LK, Liebeler CL, Blumenthal MN, Rosenberg A: Variable binding affinities for allergen suggest a ‘selective competition’ among immunoglobulins in atopic and non-atopic humans. Mol Immunol 2002;39:367–377.
8.
Jackola DR, Liebeler CL, Blumenthal MN, Rosenberg A: Random outcomes of allergen-specific responses in atopic families. Clin Exp Allergy 2004;34:540–547.
9.
Jackola DR, Liebeler CL, Lin CY, Chiu YK, Blumenthal MN, Rosenberg A: Evidence that negative feedback between antibody concentration and affinity regulates humoral response consolidation to a non-infectious antigen in infants. Mol Immunol 2005;42:19–30.
10.
Lazarus R, Vercelli D, Palmer LJ, Klimecki WJ, Silverman EK, Richter B, Riva A, Ramoni M, Martinez FD, Weiss ST, Kwiatkowski DJ: Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 2002;190:9–25.
11.
Medzhitov R, Janeway CA Jr: Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;92:295–298.
12.
Dobrovolskaia MA, Vogel SN: Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002;4:903–914.
13.
Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD: A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999;20:976–983.
14.
Koppelman GH, Reijmerink NE, Stine OC, Howard TD, Whittaker PA, Meyers DA, Postma DS, Bleecker ER: Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001;163:965–969.
15.
Leung TF, Tang NLS, Sung YM, Li AM, Wong GWK, Chan HIS, Lam CWK: The C-159T polymorphisms in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol 2003;14:255–260.
16.
Sengler C, Haider A, Sommerfeld C, Lau S, Baldini M, Martinez F, Wahn U, Nickel R, German MAS: Evaluation of the CD14 C-159T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy 2003;33:166–169.
17.
Ober C, Tsalenko A, Parry R, Cox NJ: A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet 2000;67:1154–1162.
18.
CSGA (Collaborative Study on the Genetics of Asthma): A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997;15:389–392.
19.
Pierson-Mullany LK, Jackola DR, Blumenthal MN, Rosenberg A: Evidence of an affinity threshold for IgE-allergen binding in the percutaneous skin test reaction. Clin Exp Allergy 2002;32:1–10.
20.
Dobson AJ: An Introduction to Generalized Linear Models, ed 2. Boca Raton, Chapman & Hall, 2002.
21.
Jackola DR, Blumenthal MN, Rosenberg A: Evidence for two independent distributions of serum immunoglobulin E in atopic families: cognate and non-cognate IgE. Hum Immunol 2004;65:20–30.
22.
Jackola DR, Pierson-Mullany L, Blumenthal MN, Rosenberg A: Allergen skin test reaction patterns in children (≤10 years old) from atopic families suggest age-dependent changes in allergen-IgE binding in early life. Int Arch Allergy Immunol 2003;132:364–372.
23.
Jackola DR, Pierson-Mullany LK, Daniels LR, Corazalla E, Rosenberg A, Blumenthal MN: Robustness into advanced age of atopy-specific mechanisms in atopy-prone families. J Gerontol Biol Sci 2003;58A:B99–B107.
24.
Hattevig G, Kjellman B, Björkstén B: Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol 1993;4:182–186.
25.
Pierson L, Allauzen S, Blumenthal M, Rosenberg A: An automated method for determination of antibody affinity functions with nanogram quantities. J Immunol Methods 1998;211:97–109.
26.
McHeyzer-Williams LJ, Driver DJ, McHeyzer-Williams MG: Germinal center reaction. Curr Opin Hematol2001;8:52–59.
27.
Liu YJ, Malisan F, de Bouteiller O, Guret C, Lebecque S, Banchereau J, Mills FC, Max EE, Martinez-Valdez H: Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 1996;4:241–250.
28.
Hodgkin PD, Lee JH, Lyons AB: B cell differentiation and isotype switching is related to division cycle number. J Exp Med 1996;184:277–281.
29.
Hasbold J, Lyons AB, Kehry MR, Hodgkin PD: Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur J Immunol 1998;28:1040–1051.
30.
Reljic R, Wagner SD, Peakman LJ, Fearon DT: Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med 2000;192:1841–1847.
31.
Triantafilou M, Triantafilou K: Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002;23:301–304.
32.
Lue KH, Lauener RP, Winchester RJ, Geha RS, Vercelli D: Engagement of CD14 on human monocytes terminates T cell proliferation by delivering a negative signal to T cells. J Immunol 1991;147:1134–1138.
33.
Jabara HH, Vercelli D: Engagement of CD14 on monocytes inhibits the synthesis of human Igs, including IgE. J Immunol 1994;153:972–978.
34.
Rey Nores JE, Bensussan A, Vita N, Stelter F, Arias MA, Jones M, Lefort S, Borysiewicz LK, Ferrara P, Labeta MO: Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 1999;29:265–276.
35.
Arias MA, Nores JER, Vita N, Stelter F, Borysiewicz LK, Ferrara P, Labeta MO: Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol 2000;163:3480.
36.
LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, Vercelli DA: Common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001;167:5838–5844.
37.
Martinez FD, Holberg CJ, Halonen M, Morgan WJ, Wright AL, Taussig LM: Evidence for Mendelian inheritance of serum IgE levels in Hispanic and non-Hispanic white families. Am J Hum Genet 1994;55:555–565.
38.
Xu J, Postma DS, Howard TD, Koppelman GH, Zheng SL, Stine OC, Bleecker ER, Meyers DA: Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet 2000;67:1163–1173.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.